Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
ASO Visual Abstract: A Prospective, Multi-Center Randomized Controlled Trial (RCT) of the da Vinci SP Surgical System Versus Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
Journal: Annals of surgical oncology
Published: July 23, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
A Prospective, Multicenter Randomized Controlled Trial (RCT) of the da Vinci SP® Surgical System versus Open Surgery in Nipple-Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
Journal: Annals of surgical oncology
Published: April 28, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.
Journal: Cancer discovery
Published: January 11, 2026
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 10, 2025
Understanding Trends in Incidence and Management of Pregnancy-Associated Breast Cancer in a National Sample Using Claims Data.
Journal: Journal of surgical oncology
Published: November 10, 2024
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Journal: Nature communications
Published: October 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 17, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 08, 2024
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.
Journal: Cancer discovery
Published: April 04, 2024
Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models.
Journal: Cancer research communications
Published: March 31, 2024
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Last Updated: 09/26/2026